TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
2.5.2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
2.5.3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CANCER
3.1.2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
3.1.3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
3.2. KEY RESTRAINTS
3.2.1. HIGH RISK OF INFECTION FOR PATIENTS
3.2.2. HIGH COST OF BIOPSY PROCEDURES
3.2.3. LACK OF SKILLED PROFESSIONALS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. SURGE IN THE HEALTHCARE EXPENDITURE
4.1.2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
4.1.3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTIONS
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. VALUE CHAIN ANALYSIS
4.4.1. RAW MATERIALS
4.4.2. MANUFACTURERS
4.4.3. DISTRIBUTION
4.4.4. END-USERS
5. MARKET BY PRODUCT
5.1. NEEDLE- BASED BIOPSY GUNS
5.1.1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
5.1.2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
5.1.3. CORE NEEDLE BIOPSY (CNB) DEVICES
5.2. BIOPSY GUIDANCE SYSTEMS
5.3. BIOPSY NEEDLES
5.4. BIOPSY FORCEPS
5.5. OTHER PRODUCTS
6. MARKET BY APPLICATION
6.1. ONCOLOGY
6.2. GASTROENTEROLOGY
6.3. PULMONOLOGY
6.4. DERMATOLOGY
6.5. OTHER APPLICATIONS
7. MARKET BY END USE
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
7.3. DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. ASIA-PACIFIC BIOPSY DEVICES MARKET DRIVERS
8.1.3. ASIA-PACIFIC BIOPSY DEVICES MARKET CHALLENGES
8.1.4. KEY PLAYERS IN ASIA-PACIFIC BIOPSY DEVICES MARKET
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. INDIA
8.1.5.4. SOUTH KOREA
8.1.5.5. TAIWAN
8.1.5.6. SINGAPORE
8.1.5.7. AUSTRALIA & NEW ZEALAND
8.1.5.8. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. CARDINAL HEALTH
9.2.2. HOLOGIC INC
9.2.3. DANAHER CORPORATION
9.2.4. CONMED CORPORATION
9.2.5. COOK MEDICAL
9.2.6. DTR MEDICAL
9.2.7. INRAD INC
9.2.8. BOSTON SCIENTIFIC
9.2.9. MEDTRONIC PLC
9.2.10. BECTON DICKINSON AND COMPANY
9.2.11. MAMMOTOME
9.2.12. ARGON MEDICAL DEVICES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES
TABLE 2: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: KEY PLAYERS OPERATING IN ASIA-PACIFIC BIOPSY DEVICES MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer